Global Radiopharmaceuticals Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report ID: ARS11736 | Category: Healthcare | Pages: 118 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3350.00 Multi User-$5700.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Radiopharmaceuticals, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceuticals.

The Radiopharmaceuticals market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Radiopharmaceuticals market size in 2022 is 5326.4 million US dollars, and it is expected to be 10982.0 million US dollars by 2029, with a compound annual growth rate of 10.89% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Radiopharmaceuticals market include Cardinal Health (U.S.), GE Healthcare (U.S.), Lantheus Medical Imaging (U.S.), Bayer AG (Germany), and Bracco Imaging (Italy). The share of the top 3 players in the Radiopharmaceuticals market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Radiopharmaceuticals market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Diagnostic Procedures accounted for XX% of Radiopharmaceuticals market in 2022. Therapeutic Procedures share of XX%.
Hospitals accounted for XX% of the Radiopharmaceuticals market in 2022. Ambulatory Surgical Centers accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, and global Radiopharmaceuticals market status and forecast by region.
Chapters 2-3: Segmented the global Radiopharmaceuticals market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 4: Analysis of the competitive environment of Radiopharmaceuticals market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Radiopharmaceuticals market country segmentation data.
Chapter 10: Analyzes the main companies in the Radiopharmaceuticals industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 12: The main points and conclusions of the report.
Chapter 13: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria

Player list
Cardinal Health (U.S.)
GE Healthcare (U.S.)
Lantheus Medical Imaging (U.S.)
Bayer AG (Germany)
Bracco Imaging (Italy)
Nordion (Canada)
Advanced Accelerator Applications (France)
NTP Radioisotopes (South Africa)
NorthStar Medical Radioisotopes (U.S.)
Eckert & Ziegler (Germany)
Braun Melsungen AG (Germany)
Smith+Nephew (Germany)
Zimmer Biomet (U.S.)
Hanger Inc. (U.S.)
Otto Bock Healthcare GmBH (Germany)

Types list
Diagnostic Procedures
Therapeutic Procedures

Application list
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Cancer Research Institutes
Others

Table of Content

1 Radiopharmaceuticals Market Overview
1.1 Radiopharmaceuticals Product Overview
1.1.1 Radiopharmaceuticals Product Scope
1.1.2 Radiopharmaceuticals Market Status and Outlook
1.2 Global Radiopharmaceuticals Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Radiopharmaceuticals Market Size by Region (2018-2029)
1.4 Global Radiopharmaceuticals Historic Market Size by Region (2018-2023)
1.5 Global Radiopharmaceuticals Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Radiopharmaceuticals Market Size (2018-2029)
1.6.1 North America Radiopharmaceuticals Market Size (2018-2029)
1.6.2 Europe Radiopharmaceuticals Market Size (2018-2029)
1.6.3 Asia-Pacific Radiopharmaceuticals Market Size (2018-2029)
1.6.4 Latin America Radiopharmaceuticals Market Size (2018-2029)
1.6.5 Middle East & Africa Radiopharmaceuticals Market Size (2018-2029)
2 Radiopharmaceuticals Market Overview by Type
2.3 Global Radiopharmaceuticals Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Radiopharmaceuticals Historic Market Size by Type (2018-2023)
2.5 Global Radiopharmaceuticals Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Radiopharmaceuticals Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Radiopharmaceuticals Market Size Breakdown by Type
2.6.3 Asia-Pacific Radiopharmaceuticals Market Size Breakdown by Type
2.6.4 Latin America Radiopharmaceuticals Market Size Breakdown by Type
2.6.5 Middle East and Africa Radiopharmaceuticals Market Size Breakdown by Type
3 Radiopharmaceuticals Market Overview by Application
3.3 Global Radiopharmaceuticals Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Radiopharmaceuticals Historic Market Size by Application (2018-2023)
3.5 Global Radiopharmaceuticals Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Radiopharmaceuticals Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Radiopharmaceuticals Market Size Breakdown by Application
3.6.3 Asia-Pacific Radiopharmaceuticals Market Size Breakdown by Application
3.6.4 Latin America Radiopharmaceuticals Market Size Breakdown by Application
3.6.5 Middle East and Africa Radiopharmaceuticals Market Size Breakdown by Application
4 Radiopharmaceuticals Competition Analysis by Players
4.1 Global Radiopharmaceuticals Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2022)
4.3 Date of Key Players Enter into Radiopharmaceuticals Market
4.4 Global Top Players Radiopharmaceuticals Headquarters and Area Served
4.5 Key Players Radiopharmaceuticals Product Solution and Service
4.6 Competitive Status
4.6.1 Radiopharmaceuticals Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Radiopharmaceuticals Market Segment by Country
5.1 North America Radiopharmaceuticals Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Radiopharmaceuticals Market Segment by Country
6.1 Europe Radiopharmaceuticals Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Radiopharmaceuticals Market Segment by Country
7.1 Asia-Pacific Radiopharmaceuticals Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Radiopharmaceuticals Market Segment by Country
8.1 Latin America Radiopharmaceuticals Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Radiopharmaceuticals Market Segment by Country
9.1 Middle East & Africa Radiopharmaceuticals Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1  Cardinal Health (U.S.)
10.1.1 Cardinal Health (U.S.) Information
10.1.2 Business Overview
10.1.3 Cardinal Health (U.S.) Radiopharmaceuticals Revenue, Gross Margin
10.1.4 Radiopharmaceuticals Products Offered
10.1.5 Cardinal Health (U.S.) Recent Development
10.2  GE Healthcare (U.S.)
10.2.1 GE Healthcare (U.S.) Information
10.2.2 Business Overview
10.2.3 GE Healthcare (U.S.) Radiopharmaceuticals Revenue, Gross Margin
10.2.4 Radiopharmaceuticals Products Offered
10.2.5 GE Healthcare (U.S.) Recent Development
10.3  Lantheus Medical Imaging (U.S.)
10.3.1 Lantheus Medical Imaging (U.S.) Information
10.3.2 Business Overview
10.3.3 Lantheus Medical Imaging (U.S.) Radiopharmaceuticals Revenue, Gross Margin
10.3.4 Radiopharmaceuticals Products Offered
10.3.5 Lantheus Medical Imaging (U.S.) Recent Development
10.4  Bayer AG (Germany)
10.4.1 Bayer AG (Germany) Information
10.4.2 Business Overview
10.4.3 Bayer AG (Germany) Radiopharmaceuticals Revenue, Gross Margin
10.4.4 Radiopharmaceuticals Products Offered
10.4.5 Bayer AG (Germany) Recent Development
10.5  Bracco Imaging (Italy)
10.5.1 Bracco Imaging (Italy) Information
10.5.2 Business Overview
10.5.3 Bracco Imaging (Italy) Radiopharmaceuticals Revenue, Gross Margin
10.5.4 Radiopharmaceuticals Products Offered
10.5.5 Bracco Imaging (Italy) Recent Development
10.6  Nordion (Canada)
10.6.1 Nordion (Canada) Information
10.6.2 Business Overview
10.6.3 Nordion (Canada) Radiopharmaceuticals Revenue, Gross Margin
10.6.4 Radiopharmaceuticals Products Offered
10.6.5 Nordion (Canada) Recent Development
10.7  Advanced Accelerator Applications (France)
10.7.1 Advanced Accelerator Applications (France) Information
10.7.2 Business Overview
10.7.3 Advanced Accelerator Applications (France) Radiopharmaceuticals Revenue, Gross Margin
10.7.4 Radiopharmaceuticals Products Offered
10.7.5 Advanced Accelerator Applications (France) Recent Development
10.8  NTP Radioisotopes (South Africa)
10.8.1 NTP Radioisotopes (South Africa) Information
10.8.2 Business Overview
10.8.3 NTP Radioisotopes (South Africa) Radiopharmaceuticals Revenue, Gross Margin
10.8.4 Radiopharmaceuticals Products Offered
10.8.5 NTP Radioisotopes (South Africa) Recent Development
10.9  NorthStar Medical Radioisotopes (U.S.)
10.9.1 NorthStar Medical Radioisotopes (U.S.) Information
10.9.2 Business Overview
10.9.3 NorthStar Medical Radioisotopes (U.S.) Radiopharmaceuticals Revenue, Gross Margin
10.9.4 Radiopharmaceuticals Products Offered
10.9.5 NorthStar Medical Radioisotopes (U.S.) Recent Development
10.10  Eckert & Ziegler (Germany)
10.10.1 Eckert & Ziegler (Germany) Information
10.10.2 Business Overview
10.10.3 Eckert & Ziegler (Germany) Radiopharmaceuticals Revenue, Gross Margin
10.10.4 Radiopharmaceuticals Products Offered
10.10.5 Eckert & Ziegler (Germany) Recent Development
10.11  Braun Melsungen AG (Germany)
10.11.1 Braun Melsungen AG (Germany) Information
10.11.2 Business Overview
10.11.3 Braun Melsungen AG (Germany) Radiopharmaceuticals Revenue, Gross Margin
10.11.4 Radiopharmaceuticals Products Offered
10.11.5 Braun Melsungen AG (Germany) Recent Development
10.12  Smith+Nephew (Germany)
10.12.1 Smith+Nephew (Germany) Information
10.12.2 Business Overview
10.12.3 Smith+Nephew (Germany) Radiopharmaceuticals Revenue, Gross Margin
10.12.4 Radiopharmaceuticals Products Offered
10.12.5 Smith+Nephew (Germany) Recent Development
10.13  Zimmer Biomet (U.S.)
10.13.1 Zimmer Biomet (U.S.) Information
10.13.2 Business Overview
10.13.3 Zimmer Biomet (U.S.) Radiopharmaceuticals Revenue, Gross Margin
10.13.4 Radiopharmaceuticals Products Offered
10.13.5 Zimmer Biomet (U.S.) Recent Development
10.14  Hanger Inc. (U.S.)
10.14.1 Hanger Inc. (U.S.) Information
10.14.2 Business Overview
10.14.3 Hanger Inc. (U.S.) Radiopharmaceuticals Revenue, Gross Margin
10.14.4 Radiopharmaceuticals Products Offered
10.14.5 Hanger Inc. (U.S.) Recent Development
10.15   Otto Bock Healthcare GmBH (Germany)
10.15.1  Otto Bock Healthcare GmBH (Germany) Information
10.15.2 Business Overview
10.15.3  Otto Bock Healthcare GmBH (Germany) Radiopharmaceuticals Revenue, Gross Margin
10.15.4 Radiopharmaceuticals Products Offered
10.15.5  Otto Bock Healthcare GmBH (Germany) Recent Development
11 Radiopharmaceuticals Market Dynamics
11.1 Radiopharmaceuticals Industry Trends
11.2 Radiopharmaceuticals Growth Drivers
11.3 Radiopharmaceuticals Market Challenges
11.4 Radiopharmaceuticals Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Radiopharmaceuticals Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?